Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-24 5:47 PM View:  | Akebia Therapeutics, Inc. (AKBA) | 29-Feb-24 | Sale | 46,570 | $1.58 | $73,580.60 | (2%) 2.41M to 2.36M | |
| 29-Feb-24 6:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-24 | Sale | 37,733 | $1.52 | $57,354.20 | (2%) 2.45M to 2.41M | |
| 02-Feb-24 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Feb-24 | Sale | 46,489 | $1.68 | $78,101.50 | (2%) 2.5M to 2.45M | |
| 02-Feb-24 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 31-Jan-24 | Grant | 603,500 | -- | -- | 32% 1.89M to 2.5M | |
| 11-Oct-23 9:58 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 80,765 | -- | -- | (100%) 80.77K to 0 | |
| 15-Jun-23 4:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-23 | Sale | 115 | $0.35 | $40.03 | (< 1%) 80.88K to 80.77K | |
| 15-Jun-23 4:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 13-Jun-23 | Grant | 47,824 | -- | -- | 145% 33.06K to 80.88K | |
| 03-Mar-23 8:01 AM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-23 | Sale | 91,868 | $0.88 | $80,614.20 | (5%) 1.98M to 1.89M | |
| 01-Mar-23 4:07 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-23 | Sale | 38,632 | $0.81 | $31,415.50 | (2%) 2.02M to 1.98M | |
| 02-Feb-23 4:15 PM View: | Akebia Therapeutics, Inc. (AKBA) | 31-Jan-23 | Grant | 293,125 | -- | -- | 17% 1.73M to 2.02M | |
| 16-Jun-22 9:48 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-22 | Grant | 23,109 | -- | -- | 231% 10.0K to 33.11K | |
| 16-Jun-22 9:48 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-22 | Sale | 53 | $1.01 | $53.53 | (< 1%) 33.11K to 33.06K | |
| 02-Mar-22 9:25 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-22 | Sale | 53,973 | $2.17 | $117,159.00 | (3%) 1.78M to 1.72M | |
| 02-Mar-22 9:25 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Grant | 293,125 | -- | -- | 19% 1.51M to 1.8M | |
| 02-Mar-22 9:25 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Sale | 25,053 | $2.15 | $53,984.20 | (1%) 1.8M to 1.78M | |
| 05-Aug-21 5:28 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 03-Aug-21 | Grant | 5,000 | -- | -- | 100% 5.0K to 10.0K | |
| 01-Apr-21 8:32 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Apr-21 | Market Sale | 4,109 | $3.40 | $13,970.60 | (< 1%) 1.54M to 1.53M | < 1% |
| 18-Mar-21 7:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 16-Mar-21 | Grant | 39,520 | -- | -- | 3% 1.5M to 1.54M | |
| 02-Mar-21 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-21 | Market Sale | 49,990 | $3.40 | $169,771.00 | (3%) 1.55M to 1.5M | |
| 02-Mar-21 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 26-Feb-21 | Grant | 237,400 | -- | -- | 18% 1.31M to 1.55M | |
| 02-Mar-20 7:26 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Grant | 237,400 | -- | -- | 22% 1.07M to 1.31M | |
| 21-Nov-19 6:32 AM View: | Akebia Therapeutics, Inc. (AKBA) | 20-Nov-19 | Market Purchase | 50,000 | $3.44 | $172,000.00 | 5% 1.02M to 1.07M | (12%) |
| 05-Jun-19 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Jun-19 | Option Exercise | 287,000 | $0.47 | $134,890.00 | 39% 731.18K to 1.02M | |
| 05-Mar-19 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-19 | Grant | 239,500 | -- | -- | 49% 491.68K to 731.18K | |
| 13-Dec-18 8:10 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Payment of Exercise | 135,697 | $8.94 | $1,213,130.00 | (22%) 627.11K to 491.42K | 66% |
| 22-Aug-18 4:39 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 22-Aug-18 | Market Purchase | 5,000 | $6.43 | $32,153.00 | 100% 0 to 5.0K | (45%) |
| 12-Jul-18 4:59 PM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Jul-18 | Option Exercise | 100,000 | $0.47 | $47,000.00 | 24% 410.31K to 510.31K | |
| 02-Mar-18 4:15 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-18 | Grant | 88,900 | -- | -- | 28% 319.91K to 408.81K | |
| 20-Jun-17 4:09 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 09-Jun-17 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 23-Feb-17 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 21-Feb-17 | Grant | 119,500 | -- | -- | 60% 198.28K to 317.78K | |
| 23-Jan-17 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 19-Jan-17 | Option Exercise | 20,000 | $0.47 | $9,400.00 | 6% 353.48K to 373.48K | |
| 02-Sep-16 12:33 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition | 2,250 | $32.00 | $72,000.00 | (44%) 5.1K to 2.85K | |
| 02-Sep-16 12:33 PM View: | Relypsa Inc (RLYP) | 01-Sep-16 | Disposition (change in control) | 2,849 | $32.00 | $91,168.00 | (100%) 2.85K to 0 | |
| 10-Feb-17 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Jul-16 | Gift | 58,400 | -- | -- | 16% 373.48K to 431.88K | |
| 10-Feb-17 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Jul-16 | Gift | 116,800 | -- | -- | (27%) 431.88K to 315.08K | |
| 23-Jun-16 5:53 PM View: | Relypsa Inc (RLYP) | 21-Jun-16 | Grant | 2,250 | -- | -- | 79% 2.85K to 5.1K | |
| 08-Jun-16 5:19 PM View: | Relypsa Inc (RLYP) | 07-Jun-16 | Market Sale | 1,013 | $19.32 | $19,570.30 | (26%) 3.86K to 2.85K | (< 1%) |
| 27-May-16 5:15 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 26-May-16 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 24-Feb-16 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 22-Feb-16 | Grant | 125,500 | -- | -- | 56% 225.67K to 351.17K | |
| 19-Jan-16 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 15-Jan-16 | Option Exercise | 25,000 | $0.47 | $11,750.00 | 12% 200.67K to 225.67K | |
| 15-Jun-15 6:40 PM View: | Relypsa Inc (RLYP) | 11-Jun-15 | Market Sale (Planned) | 1,100 | $34.62 | $38,086.50 | (22%) 4.96K to 3.86K | 2% |
| 08-Jun-15 8:52 PM View: | Relypsa Inc (RLYP) | 04-Jun-15 | Grant | 2,250 | -- | -- | 83% 2.71K to 4.96K | |
| 28-May-15 6:31 AM View: | Akebia Therapeutics, Inc. (AKBA) | 26-May-15 | Option Exercise | 50,000 | $0.47 | $23,500.00 | 34% 148.35K to 198.35K | |
| 11-Mar-15 6:23 AM View: | Akebia Therapeutics, Inc. (AKBA) | 09-Mar-15 | Option Exercise | 100,000 | $0.47 | $47,000.00 | 207% 48.35K to 148.35K | |
| 29-Dec-14 5:16 PM View: | Akebia Therapeutics, Inc. (AKBA) | 29-Dec-14 | Market Purchase (Planned) | 1,000 | $11.57 | $11,567.20 | 2% 47.35K to 48.35K | (76%) |
| 22-Dec-14 4:11 PM View: | Akebia Therapeutics, Inc. (AKBA) | 22-Dec-14 | Market Purchase (Planned) | 1,000 | $11.92 | $11,916.00 | 2% 46.35K to 47.35K | (76%) |
| 18-Dec-14 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 15-Dec-14 | Market Purchase (Planned) | 1,000 | $11.34 | $11,336.40 | 2% 45.35K to 46.35K | (75%) |
| 13-Nov-14 6:21 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Nov-14 | Market Purchase | 1,000 | $10.31 | $10,305.00 | 2% 44.35K to 45.35K | (73%) |
| 13-Nov-14 6:21 AM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Nov-14 | Option Exercise | 30,500 | $0.47 | $14,335.00 | 220% 13.85K to 44.35K | |
| 23-Jun-14 8:11 PM View: | Relypsa Inc (RLYP) | 19-Jun-14 | Grant | 2,712 | -- | -- | 100% 0 to 2.71K |